If you’re dealing with penile curvature or pain during erections, you’re not alone. Peyronie’s disease treatment has evolved significantly, offering hope to the estimated 11% of American men affected by this condition. At St. Pete Urology, our board-certified urologists understand that choosing the right treatment approach requires careful consideration of your symptoms, disease stage, and personal goals. This comprehensive guide will walk you through every available treatment option, helping you make informed decisions about your urological health and overall well-being.

Non-Surgical Treatment Options: First-Line Approaches

For men experiencing non surgical Peyronie treatment, several conservative approaches can effectively manage symptoms, particularly during the acute phase of the disease. These treatments focus on reducing inflammation, managing pain, and potentially slowing disease progression.

Oral medications represent the most accessible treatment option, though their effectiveness varies. Vitamin E, pentoxifylline, and potassium para-aminobenzoate (Potaba) have shown modest benefits in some studies. While these supplements may help reduce plaque size and curvature in early-stage disease, clinical evidence remains limited according to the National Institute of Diabetes and Digestive and Kidney Diseases.

Topical treatments offer another non-invasive approach. Verapamil gel, when applied directly to the affected area, may help reduce penile pain and curvature. However, research indicates that topical applications may not penetrate deeply enough into the tunica albuginea to provide significant structural improvements.

Injectable Treatments: FDA-Approved Solutions

Collagenase injection Peyronie therapy represents the gold standard for non-surgical treatment. Xiaflex (collagenase clostridium histolyticum) is the only FDA-approved intralesional treatment for Peyronie’s disease, specifically designed for men with penile curvature greater than 30 degrees.

Clinical trials demonstrate impressive results: patients receiving collagenase injections showed a 34% improvement in penile curvature compared to 18.2% with placebo treatments. The treatment protocol involves a series of injections administered over 8 weeks, targeting the fibrous plaque directly. Patients considering this treatment often benefit from understanding what Peyronie’s disease involves and its progression.

Other intralesional options include verapamil and interferon alpha-2b injections. Verapamil, a calcium channel blocker, helps reduce plaque formation and penile pain when injected directly into the affected tissue. Interferon therapy aims to reduce inflammation and slow scar tissue development, though results vary among patients.

Mechanical Therapies: Addressing Common Patient Concerns

Many patients ask about penile traction devices and vacuum therapy effectiveness. Penile curvature treatment using mechanical approaches has gained popularity due to their non-invasive nature and minimal side effects.

Penile traction therapy involves wearing a device that applies gentle, consistent stretching force to the penis. Studies show that dedicated use of traction devices can reduce curvature by 10-20 degrees and may increase penile length. The RestoreX device, in particular, has demonstrated significant improvements when used consistently over 3-6 months.

Vacuum erection devices offer another mechanical approach, helping maintain penile length and potentially reducing curvature progression. These devices work by creating negative pressure around the penis, encouraging blood flow and tissue flexibility. For men experiencing concurrent issues, understanding erectile dysfunction treatment options can be valuable.

Surgical Treatment Options: When Conservative Approaches Aren’t Enough

Surgery becomes necessary when Peyronie’s disease severely impacts sexual function or quality of life, typically reserved for men with stable disease lasting at least 12 months. St. Pete Urology’s experienced surgeons offer several proven surgical approaches using advanced minimally invasive surgical techniques.

Plication procedures involve shortening the longer side of the penis to match the curved side, effectively straightening the organ. This outpatient surgery preserves erectile function but may result in slight length reduction.

Grafting techniques address more severe curvatures by lengthening the affected side. Surgeons remove or incise the plaque and replace it with graft material, such as pericardium or synthetic patches. This approach maintains penile length but carries higher complication risks.

For men with concurrent erectile dysfunction, penile prosthesis implantation offers comprehensive treatment. Modern inflatable prostheses can correct curvature while restoring erectile function, providing excellent patient satisfaction rates. The American Urological Association provides detailed guidelines on surgical intervention timing and techniques.

Making Informed Treatment Decisions

Choosing the right Peyronie’s disease treatment depends on multiple factors: disease stage, severity of symptoms, erectile function, and personal preferences. Early intervention during the acute phase often yields the best outcomes, preventing progression and maintaining sexual function.

At St. Pete Urology, our team of board-certified specialists—Dr. Reid Graves, Dr. Nicholas Laryngakis, Dr. Adam Oppenheim, and Dr. Ankur Shah—brings extensive experience in both non-surgical and surgical Peyronie’s disease management. We utilize the latest techniques, including da Vinci robotic surgery and advanced intralesional therapies, to provide personalized treatment plans.

Don’t let Peyronie’s disease impact your quality of life and relationships. For comprehensive information about treatment options and outcomes, the Mayo Clinic offers additional resources. Contact St. Pete Urology at (727) 478-1172 to schedule a consultation and explore your treatment options with compassionate, expert care.

---

References:

1. Nehra, A., Alterowitz, R., Culkin, D. J., et al. (2015). Peyronie’s disease: AUA guideline. Journal of Urology, 194(3), 745-753. https://www.auanet.org/guidelines-and-quality/guidelines/peyronies-disease-guideline
   
2. Cocci, A., Russo, G. I., Briganti, A., et al. (2018). Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie’s disease. BJU International, 122(4), 680-687. https://pubmed.ncbi.nlm.nih.gov/29883540/
3. Stuntz, M., Perlaky, A., des Vignes, F., Kyriakides, T., & Glass, D. (2016). The prevalence of Peyronie’s disease in the United States: A population-based study. PLoS One, 11(2), e0150157. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0150157
4. National Institute of Diabetes and Digestive and Kidney Diseases. (2024). Penile curvature (Peyronie’s disease). U.S. Department of Health and Human Services. https://www.niddk.nih.gov/health-information/urologic-diseases/penile-curvature-peyronies-disease